Publication: Molecular subtypes of ductal carcinoma in situ (DCIS) identified by expression of ER, PR, HER2, and Ki-67
Issued Date
2019-01-01
Resource Type
ISSN
22288082
Other identifier(s)
2-s2.0-85077632579
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Siriraj Medical Journal. Vol.71, No.6 (2019), 432-437
Suggested Citation
Warapan Numprasit, Irin Chowchankit, Suebwong Chuthapisith, Malee Warnnissorn, Waraporn Imruetaicharoenchoke Molecular subtypes of ductal carcinoma in situ (DCIS) identified by expression of ER, PR, HER2, and Ki-67. Siriraj Medical Journal. Vol.71, No.6 (2019), 432-437. doi:10.33192/Smj.2019.64 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/51993
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Molecular subtypes of ductal carcinoma in situ (DCIS) identified by expression of ER, PR, HER2, and Ki-67
Other Contributor(s)
Abstract
© 2019, Faculty of Medicine Siriraj Hospital, Mahidol University. Objective: The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and Ki-67 are used to classify invasive breast cancer into various subtypes. In the case of ductal carcinoma in situ (DCIS), however, the information relating to subtypes using these markers is still limited.Methods: The pathological specimens of 267 patients diagnosed with DCIS at Siriraj Hospital were analyzed. By using the expressions of ER, PR, HER2, and Ki-67, breast cancer patients were classified into the five molecular subtypes: luminal A, luminal B/HER2 negative, luminal B/HER2 positive, HER2 overexpression, and triple-negative. Based on the specific molecular subtypes, age, clinical presentation, tumor size, and tumor grade were analyzed separately using univariate analysis.Results: 135 (50.6%), 1 (0.4%), 58 (21.7%), 59 (22.1%), and 14 (5.2%) DCIS were luminal A, luminal B/HER2 negative, luminal B/HER2 positive, HER2 overexpression, and triple-negative, respectively. Patients with luminal A DCIS significantly presented with mass, compared to the other subtypes that displayed with mass and microcalcification in combination (p = 0.008). The luminal A subtype was also associated with tumors of a smaller size (less than 2 cm; p = 0.007) and a lower nuclear grade (p = 0.000) than the HER2 overexpression subtype.Conclusion: Although luminal A DCIS was the most common DCIS subtype of Thai women, HER2 overexpression DCIS was significantly correlated with poor clinicopathological features, including a large tumor size and a high nuclear grade, which are recognized prognostic factors for tumor recurrence.